WCP
SSKN

Wick Capital Partners’s Strata Skin Sciences SSKN Stock Holding History

Wick Capital Partners’s Portfolio SSKN Stock Details SSKN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,313
Closed -$20K – 63
2022
Q3 		$20K Hold
2,313
– – 0.01% 50
2022
Q2 		$22K Buy
+2,313
New +$27.5K 0.02% 49

Other funds holding SSKN

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
2L
22NW LP Seattle, Washington $105M AUM 38.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $149M AUM 39.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
MOS
MGO One Seven Beachwood, Ohio $6.06B AUM 28.9% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

Wick Capital Partners's SSKN Position: Q4 2022 in Review

Wick Capital Partners sold out of Strata Skin Sciences (SSKN) in Q4 2022, closing a stake of 2,313 shares — an estimated $20K sold.

Wick Capital Partners first reported a position in SSKN in Q2 2022 and held it in 2 quarters. The position peaked at $22K in Q2 2022. 28 funds tracked by Wall St. Rank hold SSKN as of Q4 2022.

  • Wick Capital Partners reported no remaining Strata Skin Sciences position as of Q4 2022 after selling out during the quarter.
  • Wick Capital Partners sold 2,313 Strata Skin Sciences shares in Q4 2022, an estimated $20K.
  • Wick Capital Partners first reported a position in Strata Skin Sciences in Q2 2022 and held it in 2 quarters.
  • Wick Capital Partners's Strata Skin Sciences position peaked at $22K in Q2 2022.
  • 28 funds tracked by Wall St. Rank held Strata Skin Sciences as of Q4 2022.

Based on Wick Capital Partners's 13F filing for Q4 2022, filed 14 Feb 2023.